<DOC>
	<DOCNO>NCT02653898</DOCNO>
	<brief_summary>Antimalarial drug resistance reach critical level Thai-Cambodian border . Many begin advocate concert malaria elimination effort Cambodia . However , currently consensus malaria elimination achieve tool available . In study , investigator conduct operational research Royal Cambodian Armed Forces ( RCAF ) National Malaria Center ( CNM ) quantify relative effectiveness two major interventional approach - monthly malaria prophylaxis ( MMP ) focus screen treatment ( FSAT ) - head to-head comparison . In addition , investigator quantify relative contribution recently advocate vector intervention military personnel - insecticide treat uniform ( ITU ) - addition vector control measure currently employ RCAF . The investigator employ permethrin insecticide self-application kit currently use US military . The investigator estimate cost effectiveness approach attempt define best way forward malaria elimination effort critically important malaria reservoir military population ( dependent ) reside Thai-Cambodian border . The aim study conduct research well define best way forward malaria elimination effort high risk military population , also build capacity within RCAF support lead future elimination effort difficult-to-reach mobile population .</brief_summary>
	<brief_title>Malaria Elimination Pilot Study Military Forces Cambodia</brief_title>
	<detailed_description>This cluster-randomized , open label interventional study determine feasibility achieve significant reduction malaria case military encampment Thai-Cambodian border . The study compare effectiveness , safety , tolerability monthly malaria prophylaxis ( MMP ) monthly focus screen treatment ( FSAT ) . This study thus investigate effectiveness two potential intervention malaria elimination . Subjects monthly malaria prophylaxis ( MMP ) arm receive standard 3-day treatment course dihydroartemisinin-piperaquine month 1 , 2 3 weekly low-dose primaquine ( 22.5mg 12 week ) . Volunteers focus screen treatment ( FSAT ) arm screen monthly treat malaria follow national treatment guideline . For G6PD-deficient volunteer FSAT arm , primaquine administer weekly ( 45mg 8 week ) radical curative and/or presumptive anti-relapse therapy . For G6PD normal volunteer vivax infection , primaquine administer daily ( 15mg 14 day ) . All FSAT volunteer confirm P. falciparum infection receive single , low dose ( 15mg ) Primaquine P. falciparum transmission-blocking agent . The incremental benefit insecticide treat uniform ( ITU ) also assess single-blind sham-controlled intervention addition personal protective measure currently employ RCAF . Volunteers follow monthly total 6 month , determine proportion remain malaria-free day 180 follow enrollment .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Parasitic Diseases</mesh_term>
	<mesh_term>Dihydroartemisinin</mesh_term>
	<mesh_term>Primaquine</mesh_term>
	<mesh_term>Piperaquine</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Mefloquine</mesh_term>
	<mesh_term>Antimalarials</mesh_term>
	<mesh_term>Permethrin</mesh_term>
	<criteria>1 . Military volunteer age 1865 year age plus dependent &gt; 2 year age , eligible care RCAF facility , otherwise eligible Cambodian civilian risk contract malaria live within designated geographical area 2 . Able give inform consent/assent 3 . Resides select study area , available monthly followup 6 month study duration 4 . Agrees seek outside medical care febrile illness unless refer study team 5 . Authorized local commander participate study active duty 1 . Allergic reaction contraindication dihydroartemisininpiperaquine primaquine artesunate+mefloquine 2 . Pregnant lactate female , female childbearing age , 50 year age otherwise individually assess childbearing potential , agree use acceptable form contraception study 3 . Judged investigator otherwise unsuitable study participation</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Malaria</keyword>
	<keyword>Antimalarials</keyword>
	<keyword>Malaria Elimination</keyword>
	<keyword>Mass Drug Administration</keyword>
	<keyword>Malaria Prophylaxis</keyword>
	<keyword>Mobile population</keyword>
	<keyword>Drug resistance</keyword>
	<keyword>Focused screening treatment</keyword>
	<keyword>Monthly Malaria Prophylaxis</keyword>
	<keyword>Mass screening treatment</keyword>
	<keyword>Primaquine</keyword>
	<keyword>Malaria transmission</keyword>
	<keyword>Permethrin insecticide</keyword>
	<keyword>Thai-Cambodian border</keyword>
	<keyword>Cambodia</keyword>
	<keyword>AFRIMS</keyword>
</DOC>